Literature DB >> 3576119

Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).

C Orskov, J J Holst.   

Abstract

Gene-sequencing studies have shown that the glucagon precursor contains two additional glucagon-like sequences, the so-called glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). We developed radio-immunoassays against synthetic peptides corresponding to these sequences. Antisera were raised in rabbits after carbodiimide conjugation of peptides to BSA. The selected antisera showed neither mutual cross-reactivity nor cross-reacted with any other peptide of the glucagon family. Trypsin digestion experiments showed that both antisera were directed against the C-terminus of the antigen peptides. Labelling was performed with chloramine T, and separation with plasma-coated charcoal. The detection limit was 7 and 25 pmol/l for GLP-1 and GLP-2. Accurate measurement of both peptides in plasma required extraction. Optimum recovery was obtained with ethanol at 75% (final concentration). The concentrations measured in fasting plasma from 10 normal subjects were 107 +/- 7 pmol/l and 151 +/- 14 pmol/l for GLP-1 and GLP-2, respectively. After a mixed meal the concentrations rose slowly for 2 h reaching 145 +/- 13 and 225 +/- 15 pmol/l.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3576119

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  30 in total

1.  GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.

Authors:  B T Schjoldager; P E Mortensen; J Christiansen; C Orskov; J J Holst
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

2.  Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects.

Authors:  Juan Patricio Valderas; Veronica Irribarra; Lorena Rubio; Camilo Boza; Manuel Escalona; Yessica Liberona; Andrea Matamala; Alberto Maiz
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

3.  Glucagon-like peptide 1 content of intestinal tract in adult rats injected with streptozotocin either during neonatal period or 7 d before sacrifice.

Authors:  Jesús Cancelas; Verónica Sancho; Maria L Villanueva-Peñacarrillo; Philippe Courtois; Fraser W Scott; Isabel Valverde; Willy J Malaisse
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Plasma insulin, glucagon, glucagon-like peptide and glucose levels in response to feeding, starvation and life long restricted feed ration in salmonids.

Authors:  A Sundby; K A Eliassen; A K Blom; T Asgard
Journal:  Fish Physiol Biochem       Date:  1991-06       Impact factor: 2.794

5.  Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.

Authors:  A Z Zhao; K E Bornfeldt; J A Beavo
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.

Authors:  C Qualmann; M A Nauck; J J Holst; C Orskov; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

7.  Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.

Authors:  M A Nauck; M Büsing; C Orskov; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.

Authors:  Jacqueline A Koehler; Will Harper; Maja Barnard; Bernardo Yusta; Daniel J Drucker
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

Authors:  M A Nauck; N Kleine; C Orskov; J J Holst; B Willms; W Creutzfeldt
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

10.  Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

Authors:  A Wettergren; B Schjoldager; P E Mortensen; J Myhre; J Christiansen; J J Holst
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.